Alternative interventions for refractory angina
Authors:
Abstract
### Learning objectives Refractory angina (RA) is conventionally defined as a chronic condition (≥3 months in duration) characterised by angina caused by coronary insufficiency in the setting of coronary artery disease (CAD) which cannot be controlled by a combination of medical therapy, angioplasty or bypass surgery and where the presence of reversible myocardial ischaemia has been clinically established to be the cause of the symptoms.1 Precise estimates of the prevalence and incidence of RA are not available. Several sources suggest that this is a large and growing problem. Much of the difficulty arises around the definition and heterogeneity of patients labelled with a diagnosis of RA. Data from the Canadian Community Health Survey (2000–2001) suggest that approximately 500 000 Canadians are living with unresolved angina.2 The proportion of these patients living with true RA is not known.3 It is estimated that between 600 000 and 1.8 million patients in the USA have RA, with as many as 75 000 new cases diagnosed each year.4 In Europe, the annual incidence of RA is estimated at approximately 30–50 000 new cases per year.1 No specific figures exist for the UK. However, if one applies the findings of Williams et al 5 who noted that 6.7% of patients undergoing angiography in a contemporary series had no revascularisation option, to the 247 363 angiograms performed in England in 2014,6 one …Keywords
This publication has 97 references indexed in Scilit:
- Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-upJournal of Cardiovascular Translational Research, 2013
- Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Enhanced External Counterpulsation Improves Peripheral Artery Flow-Mediated Dilation in Patients With Chronic AnginaCirculation, 2010
- Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trialThe Lancet, 2010
- Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.‐2 Trial)European Journal of Clinical Investigation, 2009
- Multi-Centre Experience on the Use of Perhexiline in Chronic Heart Failure and Refractory Angina: Old Drug, New HopeEuropean Journal of Heart Failure, 2009
- VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN TrialMolecular Therapy, 2009
- Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trialEuropean Heart Journal, 2009
- Effect of Enhanced External Counterpulsation on Inflammatory Cytokines and Adhesion Molecules in Patients With Angina Pectoris and Angiographic Coronary Artery DiseaseThe American Journal of Cardiology, 2008
- Enhanced External Counterpulsation and Future DirectionsJACC, 2007